Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 84.4936 | 73 |
GSM780708 | Untreated after 4 days (C2_1) | 89.4898 | 74 |
GSM780709 | Untreated after 4 days (C3_1) | 74.1624 | 70 |
GSM780719 | Untreated after 4 days (C1_2) | 84.2656 | 73 |
GSM780720 | Untreated after 4 days (C2_2) | 92.4522 | 74 |
GSM780721 | Untreated after 4 days (C3_2) | 84.7267 | 73 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 82.461 | 72 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 81.7051 | 72 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 83.5675 | 72 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 91.1922 | 74 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 94.6958 | 74 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 76.8992 | 71 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 86.1357 | 73 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 84.682 | 73 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 74.8836 | 70 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 78.7208 | 71 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 85.3708 | 73 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 81.861 | 72 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 80.7961 | 72 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 83.2358 | 72 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 71.7324 | 70 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 79.1627 | 71 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 87.6742 | 73 |